LY-307,452 is a drug used in neuroscience research, which was among the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors ( mGluR_2/3), and was useful in early studies of this receptor family, although it has largely been replaced by newer drugs such as

LY-341,495 LY-341495 is a research drug developed by the pharmaceutical company Eli Lilly, which acts as a potent and selective orthosteric antagonist for the group II metabotropic glutamate receptors ( mGluR2/3). It is used in scientific research in severa ...

. Its molecular formula is C₂₁H₂₅NO₄

References

Drugs developed by Eli Lilly and Company MGlu2 receptor antagonists MGlu3 receptor antagonists {{nervous-system-drug-stub